SHINE Technologies, a fusion company building what is set to be the world’s largest medical isotope production facility at its Wisconsin campus, announced that it has agreed to acquire the single photon emission computed tomography (SPECT) business from Lantheus, a radiopharmaceutical-focused company based in Massachusetts.